Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.
Herrera AF, Rodig SJ, Song JY, Kim Y, Griffin GK, Yang D, Nikolaenko L, Mei M, Bedell V, Dal Cin P, Pak C, Alyea EP, Budde LE, Chen R, Chen YB, Chan WC, Cutler CS, Ho VT, Koreth J, Krishnan A, Murata-Collins JL, Nikiforow S, Palmer J, Pihan GA, Pillai R, Popplewell L, Rosen ST, Siddiqi T, Sohani AR, Zain J, Kwak LW, Weisenburger DD, Weinstock DM, Soiffer RJ, Antin JH, Forman SJ, Nademanee AP, Armand P. Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. Biol Blood Marrow Transplant. 2018 03; 24(3):514-520.
-
Corey Stephen Cutler, M.D.
-
John Koreth, M.B.,B.S.
-
David Marc Weinstock, M.D.
-
Sarah NIkiforow, M.D.,Ph.D.
-
Scott J. Rodig, Ph.D., M.D.
-
German Pihan, M.D.
-
Joseph Harry Antin, M.D.
-
Robert Jon Soiffer, M.D.
-
Philippe Armand, M.D.,Ph.D.
-
Aliyah Sohani, M.D.
-
Vincent T. Ho, M.D.
-
Gabriel Kenneth Griffin, M.D.
-
Paola S. Dal Cin, Ph.D.